This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: University of Kansas, Hylapharm, LLC, University of Michigan. Active years: 2014-2025.
Company Filing History:
5 out of 571 
2 out of 2 
2 out of 3,523 
Years Active: 2014-2025
Title: Ti Zhang: Innovator in Bone Repair and Cancer Treatment
Introduction
Ti Zhang is a prominent inventor based in Lawrence, Kansas, known for his significant contributions to the fields of bone repair and cancer treatment. With a total of 5 patents, Zhang has developed innovative technologies that aim to enhance therapeutic outcomes in these critical areas.
Latest Patents
Zhang's latest patents include groundbreaking inventions such as "Devices, compositions and related methods for accelerating and enhancing bone repair." This invention focuses on novel therapeutic nanoparticles that are associated with angiogenesis-activating agents. The technology outlines methods for synthesizing these nanoparticles and their applications in therapeutic settings to enhance angiogenesis at targeted tissue regions. Another notable patent is for "Imidazoquinoline compounds and prodrugs thereof," which involves TLR7 and TLR8 agonist compounds. This technology is aimed at treating cancers and serves as vaccine adjuvants.
Career Highlights
Throughout his career, Ti Zhang has worked at esteemed institutions such as the University of Kansas and the University of Michigan. His work has been pivotal in advancing research and development in his areas of expertise.
Collaborations
Zhang has collaborated with notable colleagues, including Laird Forrest and Daniel J Aires, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Ti Zhang's work exemplifies the impact of innovative thinking in medicine, particularly in enhancing bone repair and cancer treatment. His patents reflect a commitment to advancing healthcare through technology and research.